3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Purity ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Short Description:

Chemical Name: 3,6-Difluoropyrazine-2-Carbonitrile

CAS: 356783-28-3

Appearance: Pale Yellow to Off-White Powder

Purity: ≥99.0% (HPLC)

Intermediate of Favipiravir (CAS 259793-96-9) in the treatment of Influenza Virus Infections and COVID-19

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Commercial Supply Favipiravir and Related Intermediates:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Chemical Name	3,6-Difluoropyrazine-2-Carbonitrile
CAS Number	356783-28-3
CAT Number	RF-PI227
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C5HF2N3
Molecular Weight	141.08
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Pale Yellow to Off-White Powder
Purity	≥99.0%
Loss on Drying	≤1.0%
Residue on ignition	≤0.50%
Single Impurity	≤0.50%
Total Impurities	≤1.0%
Heavy Metals	≤20ppm
Test Standard	Enterprise Standard
Usage	Intermediate of Favipiravir (CAS: 259793-96-9)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

3,6-Difluoropyrazine-2-Carbonitrile (CAS: 356783-28-3) is an intermediate of Favipiravir (CAS: 259793-96-9). Favipiravir was approved for marketing in Japan in March 2014 and used for antiviral treatment of influenza A and B. In addition to the influenza virus, the drug also showed good antiviral activity to a variety of RNA viruses, such as Ebola virus, sand virus, Bunia virus, rabies virus, etc. Novel coronavirus pneumonia is inhibited by the latest research.